Tyson J Moyer
Tyson J Moyer
1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA USA
2Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA USA
1,2,
Yu Kato
Yu Kato
2Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA USA
3Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA USA
2,3,
Wuhbet Abraham
Wuhbet Abraham
1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA USA
1,
Jason Y H Chang
Jason Y H Chang
1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA USA
1,
Daniel W Kulp
Daniel W Kulp
2Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA USA
4Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, PA USA
5International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA USA
2,4,5,
Nicki Watson
Nicki Watson
6Whitehead Institute of Biomedical Research, Cambridge, MA USA
6,
Hannah L Turner
Hannah L Turner
2Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA USA
5International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA USA
7Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA USA
2,5,7,
Sergey Menis
Sergey Menis
2Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA USA
5International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA USA
2,5,
Robert K Abbott
Robert K Abbott
2Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA USA
3Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA USA
2,3,
Jinal N Bhiman
Jinal N Bhiman
2Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA USA
5International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA USA
8Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA USA
9Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA USA
2,5,8,9,
Mariane B Melo
Mariane B Melo
1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA USA
2Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA USA
9Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA USA
1,2,9,
Hayley A Simon
Hayley A Simon
3Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA USA
3,
Sara Herrera-De la Mata
Sara Herrera-De la Mata
3Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA USA
3,
Shu Liang
Shu Liang
3Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA USA
3,
Gregory Seumois
Gregory Seumois
3Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA USA
3,
Yash Agarwal
Yash Agarwal
1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA USA
10Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA USA
1,10,
Na Li
Na Li
1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA USA
1,
Dennis R Burton
Dennis R Burton
2Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA USA
5International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA USA
8Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA USA
9Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA USA
2,5,8,9,
Andrew B Ward
Andrew B Ward
2Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA USA
5International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA USA
7Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA USA
2,5,7,
William R Schief
William R Schief
2Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA USA
5International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA USA
8Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA USA
9Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA USA
2,5,8,9,
Shane Crotty
Shane Crotty
2Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA USA
3Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA USA
11Department of Medicine, University of California, San Diego, La Jolla, CA USA
2,3,11,
Darrell J Irvine
Darrell J Irvine
1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA USA
2Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA USA
9Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA USA
10Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA USA
12Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA USA
13Howard Hughes Medical Institute, Chevy Chase, MD USA
1,2,9,10,12,13,✉
1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA USA
2Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA USA
3Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA USA
4Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, PA USA
5International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA USA
6Whitehead Institute of Biomedical Research, Cambridge, MA USA
7Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA USA
8Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA USA
9Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA USA
10Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA USA
11Department of Medicine, University of California, San Diego, La Jolla, CA USA
12Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA USA
13Howard Hughes Medical Institute, Chevy Chase, MD USA
Subject terms: Vaccines, Humoral immunity, Adjuvants, Protein vaccines, Preclinical research
© The Author(s), under exclusive licence to Springer Nature America, Inc. 2020
This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.